Stay updated on Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Sign up to get notified when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.

Latest updates to the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter metadata updated from Revision v3.2.0 to v3.3.2. This is a minor metadata update and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRemoved the temporary government funding status notice from the page; no study content or functionality was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedCore trial information such as design, outcomes, eligibility criteria, and locations remains unchanged; observed differences appear to be formatting or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedCore content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check70 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' link.SummaryDifference0.2%

Stay in the know with updates to Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.